Application no. and date | 12734733.4 (espacenet) (Federated) (European Patent Register), 20120113 | Patent/reg. no. and date | DK/EP 2663579, 20170426 | Publication date | 20131120 | Priority no. and date | US 201161433043 P, 20110114 | EP pub. no. and date |
EP 2663579 20131120 | Effective date | | Applicant/owner | The Regents of the University of California, 1111 Franklin Street, 12th Floor
Oakland, CA 94607-5200, US | Applicant ref. no. | T5509_DK | Inventor | KIPPS, Thomas, J., 13175 Caminito Mendiola
San Diego, CA 92130, US, WIDHOPF II, George, F., 5911 Seacrest View Road
San Diego, CA 92121, US, CUI, Bing, 13591 Fallhaven Road
San Diego, CA 92129, US | Representative | Orsnes Patent ApS, Sentvedvej 23, 5853 Ørbæk, DK | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | Title | TERAPEUTISKE ANTISTOFFER MOD ROR-1-PROTEIN OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | Int. application no. | US2012021339 | Int. publication no. | WO2012097313 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|